About Dr. Morepen Limited
Data last updated:
Dr. Morepen Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Morepen Laboratories Limited. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 11 July 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2001PLC111636. Its GSTIN is 07AABCD4166G1ZT (Delhi). The company holds 18 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹131 Cr and a paid-up capital of ₹127.25 Cr. It was formerly known as Doctor Morepen Limited. It is led by directors including Varun Suri (Managing Director) and Sharad Jain.
Its last annual general meeting (AGM) was held on 06 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 409 Antriksh Bhawan 22 K.G. Marg, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2025, the company reported a revenue of ₹170.92 Cr, a growth of 81% compared to the previous year. For the same year it recorded a net profit of ₹10.01 Cr (net margin 5.9%) and EBITDA of ₹14.87 Cr (EBITDA margin 8.7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 21% over five years.
The company has about 231 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹88 Lakh and satisfied charges of ₹11.18 Cr on record. Court records list 221 cases involving the company, including 194 filed by the company and 27 filed against it; 74 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website morepen.com.
Company details
Contact details
Dr. Morepen Limited's registered office is in New Delhi, Delhi. Its website is morepen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address409 Antriksh Bhawan 22 K.G. Marg, New Delhi, Delhi, India – 110001
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Dr. Morepen Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dr. Morepen is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dr. Morepen Limited, buy the company report.
Financials of Dr. Morepen Limited
FY 2025 filings availableDr. Morepen Limited reported revenue of ₹170.92 Cr (up 81% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 81% growth in the latest year. EBITDA rose 361% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.87 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.7% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr. Morepen Limited, buy the company report.
Board of directors of Dr. Morepen Limited
Dr. Morepen has 4 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aakriti Suri | Additional Director | 14 Nov 2025 | 0 Years 11 Months | Current |
| Varun Suri | Managing Director | 11 Nov 2021 | 4 Years 11 Months | Current |
| Sharad Jain Also directs: Morepen Laboratories Limited | Director | 27 Aug 2024 | 2 Years 1 Months | Current |
| Ranjit Khattar Also directs: Xpress Funding Advisors LLP, Morepen Laboratories Limited, Eldeco Sohna Projects Limited and 5 more | Director | 12 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Dr. Morepen Limited is compared with the 8 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anzen Exports Private Limited | ₹173.73 Cr (FY 2025) | 27.0% | Kolkata, West Bengal, India | |||
| Dhanvanthri Speciality Pharma Private Limited | ₹172.95 Cr (FY 2024) | 41.0% | Bangalore, Karnataka, India | |||
| Medsource Healthcare Private Limited | ₹172.66 Cr (FY 2019) | -40.0% | New Delhi, Delhi, India | |||
| Farmachem Life Private Limited | ₹171.18 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Goa Medicos Private Limited | ₹171.03 Cr (FY 2025) | 5.0% | Gurgaon, Haryana, India | |||
| Dr. Morepen Limitedthis company | ₹170.92 Cr (FY 2025) | ₹10.01 Cr | 5.9% | 81.0% | 231 | New Delhi, Delhi, India |
| Advanced Sterilization Products India Private Limited | ₹170.85 Cr (FY 2025) | 22.0% | Mumbai, Maharashtra, India | |||
| Espee Pharma Chem Private Limited | ₹168.11 Cr (FY 2025) | 8.0% | Ahmedabad, Gujarat, India | |||
| Grownbury Pharmaceuticals Private Limited | ₹167.88 Cr (FY 2025) | 29.0% | New Delhi, Delhi, India |
To see the full peer comparison of Dr. Morepen Limited, buy the company report.
Auditor
Dr. Morepen Limited is audited by S.P BABUTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.P BABUTA & ASSOCIATES | FY 2023 | 007657N |
Shareholding
The shareholding of Dr. Morepen Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dr. Morepen Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 May 2015 | 10574019 | Bmw India Financial Services Private Limited | ₹44 Lakh | Satisfied | |
| 18 May 2015 | 10574022 | Bmw India Financial Services Private Limited | ₹44 Lakh | Satisfied | |
| 09 Aug 2006 | 10016522 | Lakshmi Vilas Bank Limited | ₹10.3 Cr | Satisfied |
To see the full charge records of Dr. Morepen Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Dr. Morepen Limited has 221 court cases on record: 194 filed by Dr. Morepen, 27 filed against it. 74 cases are pending and 147 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 188 | 13 | 67 |
| High courts | 33 | 14 | 7 |
Cases on record (5 of 221)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Growtouch Pharma Private Limited 000011 | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Saveo Healthtech Private Limited and 1 other | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Krirudraa Pharma Private Limited and Ors 001660 | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Godrej Consumer Products Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Godrej Consumer Products Limited | Pending |
To see the full case history of Dr. Morepen Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr. Morepen Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Dr. Morepen has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Total Care Limited | U24246DL2000PLC105296 |
To see the full group structure of Dr. Morepen Limited, buy the company report.
Employees & EPFO
Dr. Morepen Limited has a workforce of 231 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Dr. Morepen has 18 GST registrations: 14 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCD4166G1ZT | Delhi | Active | 01 Jul 2017 |
| 10AABCD4166G1Z6 | Bihar | Active | 01 Jul 2017 |
| 18AABCD4166G1ZQ | Assam | Active | 01 Jul 2017 |
| 19AABCD4166G1ZO | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dr. Morepen Limited, buy the company report.
Recent activity
Dr. Morepen Limited has 13 board changes on record since 2007: 4 appointments and 9 cessations. The latest: Aakriti Suri was appointed as Additional Director on 14 Nov 2025.
10 earlier events are in the company report.
News
Frequently asked questions
Dr. Morepen is an active public limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 11 July 2001 (25+ years old) and is registered under CIN U24232DL2001PLC111636.
Dr. Morepen has 4 current directors:
- Varun Suri - Managing Director
- Aakriti Suri - Additional Director
- Sharad Jain - Director
- Ranjit Khattar - Director
The latest financial statements of Dr. Morepen on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 06 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dr. Morepen is 07AABCD4166G1ZT, registered in Delhi. The company has 18 GST registrations in all, of which 14 are active and 4 are cancelled or inactive. Other active GSTINs include 10AABCD4166G1Z6 (Bihar), 18AABCD4166G1ZQ (Assam), 19AABCD4166G1ZO (West Bengal).
The CIN (Corporate Identification Number) of Dr. Morepen is U24232DL2001PLC111636. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Morepen has 221 court cases on record: 194 filed by the company and 27 filed against it. 74 are pending. Most are in the district courts.
Dr. Morepen was incorporated on 11 July 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dr. Morepen by revenue are Anzen Exports Private Limited, Dhanvanthri Speciality Pharma Private Limited, Medsource Healthcare Private Limited, Farmachem Life Private Limited, Goa Medicos Private Limited and 3 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Aakriti Suri was appointed as Additional Director on 14 Nov 2025. Ajay Kumar Sharma ceased to be Director on 31 Jul 2025. Bhupender Raj Wadhwa ceased to be Director on 28 Sep 2024. Dr. Morepen has 13 board changes on record in total.
Dr. Morepen can be reached through the website morepen.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Dr. Morepen is at 409 Antriksh Bhawan 22 K.G. Marg, New Delhi, Delhi, India – 110001.